CDMO Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

Contract Development and Manufacturing Organization (CDMO) Market Overview

Contract development and manufacturing organizations (CDMOs) play a vital role in the pharmaceutical and biotechnology value chain by supporting companies with specialized capabilities across drug development, manufacturing, and commercialization. Their integrated service models enable sponsors to accelerate timelines, optimize costs, and access advanced technologies without significant capital investment, strengthening operational efficiency and innovation outcomes. The market was valued at USD 246.11 Billion in 2025. It demonstrates steady expansion, driven by increasing outsourcing trends, rising biologics demand, and growing complexity of therapeutic pipelines. The strategic collaborations, regulatory expertise, and capacity expansions continue to enhance competitiveness, positioning service providers as essential partners in modern drug development ecosystems.

Contract Development and Manufacturing Organization (CDMO) Market Growth Drivers

Rising Strategic CDMO Service Expansions to Accelerate the Market Value

The increasing demand for integrated pharmaceutical development and manufacturing solutions is driving significant market expansion, as companies seek reliable partners to improve efficiency and reduce operational risks. In August 2024, PYFAGROUP launched comprehensive contract development and manufacturing organization (CDMO) services, offering end-to-end capabilities from formulation development to commercialization, supported by advanced facilities and international expertise. This strategic initiative reflects the rising trend of outsourcing across the pharmaceutical value chain to enhance scalability and innovation. Such expansions by industry participants are expected to strengthen service adoption and contribute substantially to sustained market growth.

Contract Development and Manufacturing Organization (CDMO) Market Trends

Some of the notable trends in the market include the integration of advanced drug delivery technologies, along with brand consolidation and the expansion of end-to-end service offerings.

Integration of Advanced Drug Delivery Technologies is Likely to Enhance Market Growth

The increasing integration of advanced drug delivery and particle engineering technologies within contract development and manufacturing organizations is emerging as a significant industry trend. Companies are expanding specialized capabilities to support complex formulations, including poorly soluble molecules and novel dosage forms. For instance, in October 2025, Codis was launched as a global CDMO following the integration of Particle Dynamics and a United Kingdom manufacturing facility, strengthening its commercial-scale spray drying and amorphous solid dispersion expertise. Such strategic capability consolidation enhances technical differentiation, accelerates drug commercialization timelines, and is expected to contribute substantially to sustained market growth.

Brand Consolidation and End-to-End Service Expansion to Strengthen Contract Development and Manufacturing Organization (CDMO) Market Landscape

The consolidation of multiple specialized service providers under unified global brands is gaining momentum as CDMOs aim to deliver seamless, end-to-end development and manufacturing solutions. This trend reflects growing demand from biopharmaceutical companies for integrated partnerships across the drug lifecycle. In December 2024, SK pharmteco announced a strategic brand unification initiative, combining several established organizations into a single global CDMO platform with expanded capabilities across small molecules, gene therapy, and analytical services. Such initiatives improve operational efficiency, strengthen global presence, and enhance client engagement, thereby supporting long-term market expansion.

Contract Development and Manufacturing Organization (CDMO) Market Segmentation

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Contract Development and Manufacturing Organization (CDMO) Market Share

Oncological Diseases Segment Likely to Lead the Market by Therapeutic Area

The market is segmented into oncological diseases, cardiovascular diseases, infectious diseases, and others based on the therapeutic area. Among these, oncological diseases are expected to lead due to the increasing complexity of cancer therapeutics, strong biopharmaceutical pipelines, and growing reliance on specialized development and manufacturing partners. Rising global cancer incidence is a major growth driver. According to the World Health Organization, over 35 million new cancer cases are projected by 2050, representing a 77% increase from 2022 estimates. This escalating disease burden is anticipated to sustain long-term demand for advanced development and production capabilities.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Contract Development and Manufacturing Organization (CDMO) Market Analysis by Region

The regions included in the report are North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Among these, North America is expected to lead the market, supported by strong biopharmaceutical innovation, advanced infrastructure, and strategic investments. For instance, in January 2024, Enzene Biosciences, a subsidiary of Alkem Laboratories Ltd, announced the launch of its first CDMO manufacturing facility in Hopewell, New Jersey, United States. The expansion addresses capacity gaps for emerging biotech firms requiring clinical and commercial manufacturing support, directly aligning with rising regional demand for specialized CDMO services and reinforcing North America’s market leadership.

Leading Players in the Contract Development and Manufacturing Organization (CDMO) Market

Other key players in the market are Pfizer Inc., Famar SA, Lonza Group, LTS Lohmann Therapie-Systeme AG, Aenova Holding GmBH, Fareva SA, FUJIFILM Diosynth Biotechnologies, eXmoor Pharma, B. Braun SE, and Sanofi.

Key Questions Answered in the Contract Development and Manufacturing Organization (CDMO) Market

• What was the contract development and manufacturing organization (CDMO) market value in 2025?
• What is the contract development and manufacturing organization (CDMO) market forecast outlook for 2026-2035?
• What major factors aid the demand for the contract development and manufacturing organization (CDMO) market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major contract development and manufacturing organization (CDMO) market trends?
• Which service type is expected to dominate the market segment?
• Which therapeutic area is projected to lead the market segment?
• Which end user is anticipated to drive the market segment?
• Who are the key players in the contract development and manufacturing organization (CDMO) market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

More Insights On

Europe CDMO Market

India CDMO Market

Middle East and Africa CDMO Market

United States CDMO Market

Asia Pacific CDMO Market

Contract Development and Manufacturing Organization (CDMO) Market Report Snapshots

Contract Development and Manufacturing Organization (CDMO) Companies